199 results
8-K
EX-99.1
CYTK
Cytokinetics Inc
27 Feb 24
Cytokinetics Reports Fourth Quarter 2023 Financial Results
4:05pm
enrolling patients in ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase
8-K
EX-99.1
CYTK
Cytokinetics Inc
2 Nov 23
Cytokinetics Reports Third Quarter 2023 Financial Results
4:05pm
(SAEs) as assessed by investigators, and no patient deaths.
Announced the start of ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac
8-K
EX-99.1
mfi5k1dzfx
19 Oct 23
Regulation FD Disclosure
7:32am
8-K
0a68f ouz59
6 Oct 23
Other Events
4:32pm
8-K
EX-99
wl54txtv3 fh7zgk
3 Aug 23
Cytokinetics Reports Second Quarter 2023 Financial Results
4:00pm
8-K
EX-99.1
nv21 da3a
22 May 23
Other Events
6:43pm
8-K
jtgfagukirolaprsk9
31 Mar 23
Other Events
7:33am
8-K
dw98ofmsi hhv
8 Dec 22
Other Events
7:31am
S-3ASR
EX-4.8
lldqa
18 Nov 22
Automatic shelf registration
5:24pm
8-K
o6fu9c8m
11 Oct 22
Other Events
7:31am
8-K
6tgg0
30 Sep 22
Other Events
4:30pm
8-K
ovu8ugma582kcii
4 Aug 22
Other Events
4:04pm